Point72 Asset Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,586
| Closed | -$1.93M | – | 1636 |
|
|
2023
Q1 | $1.93M | Buy |
4,586
+2,500
| +120% | +$1.05M | 0.01% | 807 |
|
|
2022
Q4 | $2.52M | Hold |
2,086
| – | – | 0.01% | 730 |
|
|
2022
Q3 | $1.66M | Hold |
2,086
| – | – | 0.01% | 786 |
|
|
2022
Q2 | $3M | Hold |
2,086
| – | – | 0.01% | 698 |
|
|
2022
Q1 | $4.36M | Hold |
2,086
| – | – | 0.02% | 672 |
|
|
2021
Q4 | $10.2M | Hold |
2,086
| – | – | 0.04% | 480 |
|
|
2021
Q3 | $13.1M | Buy |
2,086
+1,633
| +360% | +$10.3M | 0.06% | 400 |
|
|
2021
Q2 | $4.27M | Sell |
453
-398
| -47% | -$3.75M | 0.02% | 587 |
|
|
2021
Q1 | $7.4M | Buy |
+851
| New | +$7.4M | 0.03% | 471 |
|